Johnson And Johnson Blood Clot Statistics

Concerns has been building over a small, but growing number of cases of a rare, but serious blood clotting disorder associated with the Johnson & Johnson coronavirus vaccine.

The clotting disorder is called thrombosis with thrombocytopenia syndrome (TTS), and it is rare—in 17 million people who got J&J, 54 cases of TTS were reported, 36 of those people were cared for in an intensive care unit, and nine people died (which represents over 15% of cases).

There are three vaccines authorized for use in the United States, there was hope that Johnson & Johnson’s would be an important one, partly because experts believed its one-shot dose could help with those who didn’t have access to mRNA vaccines.

But blood clots became a concern starting in April, when the government put a pause on the J&J shot after six women who received it developed rare blood clots—and one died.

All of these cases were reported to the Vaccine Adverse Events Reporting System (VAERS), a national early reporting warning system to detect safety problems with U.S.-licensed vaccines.